Variant report

Variant	nsv585439
Chromosome Location	chr20:14189779-14317390
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr20:14200766-14201092	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr20:14194646-14195061	H1-hESC	embryonic stem cell:	n/a	chr20:14194846-14194860
3	BACH1	chr20:14194690-14195019	K562	blood:	n/a	chr20:14194846-14194860
4	BATF	chr20:14213283-14213671	GM12878	blood:	n/a	n/a
5	BATF	chr20:14213355-14213690	GM12878	blood:	n/a	n/a
6	BHLHE40	chr20:14314339-14314730	GM12878	blood:	n/a	n/a
7	BHLHE40	chr20:14213326-14213653	GM12878	blood:	n/a	n/a
8	BRCA1	chr20:14245586-14245671	H1-hESC	embryonic stem cell:	n/a	n/a
9	CEBPB	chr20:14309074-14309195	A549	lung:	n/a	chr20:14309135-14309148 chr20:14309137-14309146 chr20:14309135-14309146 chr20:14309136-14309147
10	CEBPB	chr20:14265246-14265469	HepG2	liver:	n/a	chr20:14265328-14265341 chr20:14265328-14265341 chr20:14265328-14265339 chr20:14265330-14265341
11	CEBPB	chr20:14216033-14216383	A549	lung:	n/a	n/a
12	CEBPB	chr20:14215229-14215777	A549	lung:	n/a	n/a
13	CEBPB	chr20:14315804-14316095	A549	lung:	n/a	chr20:14315943-14315954 chr20:14315942-14315953
14	CEBPB	chr20:14308968-14309277	HepG2	liver:	n/a	chr20:14309135-14309148 chr20:14309137-14309146 chr20:14309135-14309146 chr20:14309136-14309147
15	CEBPB	chr20:14226064-14226419	A549	lung:	n/a	chr20:14226239-14226252 chr20:14226240-14226251 chr20:14226238-14226255
16	CEBPB	chr20:14265192-14265481	Hela-S3	cervix:	n/a	chr20:14265328-14265341 chr20:14265328-14265341 chr20:14265328-14265339 chr20:14265330-14265341
17	CEBPB	chr20:14269685-14269839	A549	lung:	n/a	n/a
18	CEBPB	chr20:14269620-14269888	IMR90	lung:	n/a	n/a
19	CEBPB	chr20:14215321-14215673	IMR90	lung:	n/a	n/a
20	CEBPB	chr20:14221682-14221789	H1-hESC	embryonic stem cell:	n/a	n/a
21	CEBPB	chr20:14215347-14215636	A549	lung:	n/a	n/a
22	CEBPB	chr20:14195407-14195452	Hela-S3	cervix:	n/a	chr20:14195430-14195441
23	CEBPB	chr20:14195398-14195596	HepG2	liver:	n/a	chr20:14195430-14195441
24	CEBPB	chr20:14311674-14311759	HepG2	liver:	n/a	chr20:14311733-14311744
25	CEBPB	chr20:14315776-14316098	HepG2	liver:	n/a	chr20:14315943-14315954 chr20:14315942-14315953
26	CEBPB	chr20:14226075-14226412	Hela-S3	cervix:	n/a	chr20:14226239-14226252 chr20:14226240-14226251 chr20:14226238-14226255
27	CEBPB	chr20:14260900-14261263	HepG2	liver:	n/a	chr20:14261071-14261082 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261070-14261081
28	CEBPB	chr20:14261036-14261171	H1-hESC	embryonic stem cell:	n/a	chr20:14261071-14261082 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261070-14261081
29	CEBPB	chr20:14215378-14215643	MCF-7	breast:	n/a	n/a
30	CEBPB	chr20:14189541-14190019	MCF-7	breast:	n/a	chr20:14189866-14189877 chr20:14189841-14189852
31	CEBPB	chr20:14307461-14307689	A549	lung:	n/a	chr20:14307575-14307586
32	CEBPB	chr20:14260937-14261232	A549	lung:	n/a	chr20:14261071-14261082 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261070-14261081
33	CEBPB	chr20:14260913-14261245	IMR90	lung:	n/a	chr20:14261071-14261082 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261072-14261081 chr20:14261070-14261081
34	CEBPB	chr20:14195400-14195600	A549	lung:	n/a	chr20:14195430-14195441
35	CEBPB	chr20:14226059-14226423	HepG2	liver:	n/a	chr20:14226239-14226252 chr20:14226240-14226251 chr20:14226238-14226255
36	CEBPB	chr20:14226048-14226432	IMR90	lung:	n/a	chr20:14226239-14226252 chr20:14226240-14226251 chr20:14226238-14226255
37	CEBPB	chr20:14200842-14201173	Hela-S3	cervix:	n/a	n/a
38	CEBPB	chr20:14269670-14269797	Hela-S3	cervix:	n/a	n/a
39	CEBPB	chr20:14189576-14189991	MCF-7	breast:	n/a	chr20:14189866-14189877 chr20:14189841-14189852
40	CEBPB	chr20:14307467-14307737	HepG2	liver:	n/a	chr20:14307575-14307586
41	CEBPB	chr20:14215334-14215682	Hela-S3	cervix:	n/a	n/a
42	CEBPB	chr20:14226125-14226338	H1-hESC	embryonic stem cell:	n/a	chr20:14226239-14226252 chr20:14226240-14226251 chr20:14226238-14226255
43	CEBPB	chr20:14216006-14216480	IMR90	lung:	n/a	n/a
44	CEBPB	chr20:14228633-14228706	HepG2	liver:	n/a	chr20:14228671-14228682
45	CEBPB	chr20:14216017-14216508	Hela-S3	cervix:	n/a	n/a
46	CEBPB	chr20:14215339-14215664	A549	lung:	n/a	n/a
47	CHD2	chr20:14200780-14201180	Hela-S3	cervix:	n/a	n/a
48	CTCF	chr20:14267600-14267750	HMEC	breast:	n/a	n/a
49	CTCF	chr20:14314170-14315417	A549	lung:	n/a	chr20:14315159-14315172 chr20:14315156-14315174
50	CTCF	chr20:14245620-14245770	GM12864	blood:	n/a	chr20:14245707-14245728 chr20:14245712-14245730

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:14307665-14307715	HCF	heart:	n/a
2	chr20:14307665-14307715	NHDF-neo	bronchial:	n/a
3	chr20:14307665-14307715	PFSK-1	brain:	n/a
4	chr20:14307665-14307715	AG09319	gingival:	n/a
5	chr20:14307665-14307715	Jurkat	blood:	n/a
6	chr20:14307665-14307715	NT2-D1	testis:	n/a
7	chr20:14307665-14307715	HCPEpiC	choroid plexus:	n/a
8	chr20:14307665-14307715	AG09309	skin:	n/a
9	chr20:14307665-14307715	HCM	heart:	n/a
10	chr20:14307665-14307715	A549	lung:	n/a
11	chr20:14307665-14307715	ovcar-3	ovarian:	n/a
12	chr20:14307665-14307715	CMK	blood:	n/a
13	chr20:14307665-14307715	SKMC	muscle:	n/a
14	chr20:14307665-14307715	SAEC	small airway:	n/a
15	chr20:14307665-14307715	K562	blood:	n/a
16	chr20:14307665-14307715	U87	brain:	n/a
17	chr20:14307665-14307715	BE2_C	brain:	n/a
18	chr20:14307665-14307715	AG04449	skin:	fetal
19	chr20:14307665-14307715	NH-A	brain:	n/a
20	chr20:14307665-14307715	GM19239	blood:	n/a
21	chr20:14307665-14307715	T-47D	breast:	n/a
22	chr20:14307665-14307715	HEK293	kidney:	embryo
23	chr20:14307665-14307715	GM12878	blood:	n/a
24	chr20:14307665-14307715	LNCaP	prostate:	n/a
25	chr20:14307665-14307715	HPAEpiC	pulmonary alveolar:	n/a
26	chr20:14307665-14307715	AG04450	lung:	fetal
27	chr20:14307665-14307715	MCF10A-Er-Src	breast:	n/a
28	chr20:14307665-14307715	H1-hESC	embryonic stem cell:	embryo
29	chr20:14307665-14307715	BJ	skin:	n/a
30	chr20:14307665-14307715	SK-N-SH_RA	brain:	n/a
31	chr20:14307665-14307715	HRPEpiC	eye:	n/a
32	chr20:14307665-14307715	GM06990	blood:	n/a
33	chr20:14307665-14307715	HIPEpiC	eye:	n/a
34	chr20:14307665-14307715	RPTEC	kidney:	n/a
35	chr20:14307665-14307715	PrEC	prostate:	n/a
36	chr20:14307665-14307715	Hela-S3	cervix:	n/a
37	chr20:14307665-14307715	MCF-7	breast:	n/a
38	chr20:14307665-14307715	ECC-1	luminal epithelium:	n/a
39	chr20:14307665-14307715	Hepatocyte	liver:	n/a
40	chr20:14307665-14307715	HL-60	blood:	n/a
41	chr20:14307665-14307715	NB4	blood:	n/a
42	chr20:14307665-14307715	HRE	kidney:	n/a
43	chr20:14307665-14307715	HAEpiC	amniotic membrane:	n/a
44	chr20:14307665-14307715	AoSMC	blood vessel:	n/a
45	chr20:14307665-14307715	HRCEpiC	kidney:	n/a
46	chr20:14307665-14307715	HCT-116	colon:	n/a
47	chr20:14307665-14307715	HUVEC	blood vessel:	n/a
48	chr20:14307665-14307715	AG10803	skin:	n/a
49	chr20:14307665-14307715	GM12892	blood:	n/a
50	chr20:14307665-14307715	GM12891	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr20:14314384..14315320-chr20:14929469..14930347,2	MCF-7	breast:
2	chr20:14246857..14249567-chr20:14268278..14270770,2	K562	blood:
3	chr20:14199868..14203458-chr20:14204053..14207149,3	MCF-7	breast:
4	chr20:14170212..14170967-chr20:14245501..14246136,3	MCF-7	breast:
5	chr20:14305353..14307056-chr20:14308528..14310326,2	MCF-7	breast:
6	chr17:41400138..41401846-chr20:14313045..14314565,2	K562	blood:
7	chr20:14199868..14203458-chr20:14204053..14207149,3	MCF-7	breast:
8	chr17:41399300..41401884-chr20:14313065..14316065,3	K562	blood:
9	chr20:14173827..14175153-chr20:14245201..14246183,6	MCF-7	breast:
10	chr20:14314454..14317198-chr20:14325361..14327046,2	K562	blood:
11	chr20:14246857..14249567-chr20:14268278..14270770,2	K562	blood:
12	chr20:14305353..14307056-chr20:14308528..14310326,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C20orf7-2	chr20:14203687-14203976	NONHSAT078711
2	lnc-SEL1L2-3	chr20:14309568-14309973	NONHSAT078712

Variant related genes	Relation type
RN7SL864P	TF binding region
RN7SL864P	CpG island

Extended variants
information (count: 3582 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:3582 , 50 per page) page: 1 2 3 4 5 6 7 ... 72

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4814290	chr20:14189779-14189780	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs540337274	chr20:14189801-14189802	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs62208977	chr20:14189809-14189810	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs554230194	chr20:14189870-14189871	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs574111360	chr20:14189996-14189997	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs543029347	chr20:14190011-14190012	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs534189660	chr20:14190046-14190047	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs376734996	chr20:14190076-14190077	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs562813089	chr20:14190101-14190102	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs531503243	chr20:14190156-14190157	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs147545069	chr20:14190184-14190185	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs564890097	chr20:14190199-14190200	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs527396441	chr20:14190268-14190269	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs578117265	chr20:14190292-14190293	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs6033902	chr20:14190306-14190307	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs547058780	chr20:14190359-14190360	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs566997844	chr20:14190364-14190365	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs201258796	chr20:14190368-14190369	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs74522956	chr20:14190406-14190407	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs549355037	chr20:14190411-14190412	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs569539562	chr20:14190465-14190466	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs185561296	chr20:14190491-14190492	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs558348425	chr20:14190580-14190581	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs571722785	chr20:14190705-14190706	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs370800642	chr20:14190755-14190756	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs189983257	chr20:14190770-14190771	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs534382637	chr20:14190857-14190858	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs539308589	chr20:14190875-14190876	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs554342351	chr20:14190952-14190953	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs73264817	chr20:14191010-14191011	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs536692635	chr20:14191032-14191033	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs556549173	chr20:14191037-14191038	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs35649080	chr20:14191054-14191055	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs7261715	chr20:14191071-14191072	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs138526717	chr20:14191124-14191125	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs572172694	chr20:14191144-14191145	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs535278076	chr20:14191196-14191197	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs540809744	chr20:14191200-14191201	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs7261965	chr20:14191224-14191225	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs578118076	chr20:14191239-14191240	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs1885948	chr20:14191333-14191334	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs549377013	chr20:14191344-14191345	Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs185190785	chr20:14191423-14191424	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs191024844	chr20:14191459-14191460	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs551816033	chr20:14191518-14191519	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs141618388	chr20:14191522-14191523	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs201595422	chr20:14191524-14191525	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs6042586	chr20:14191560-14191561	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
49	rs2327819	chr20:14191572-14191573	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs183916811	chr20:14191592-14191593	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Breast cancer	16397240	CNVD
abortions and stillbirths	19751515	CNVD
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Glaucoma	21310917	CNVD
Alagille syndrome	22470819	CNVD
Lung cancer	16773561	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Myelofibrosis	22110671	CNVD
Kabuki syndrome	21720541	CNVD
Glioblastoma multiforme	22286061	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Neurocytoma	17123091	CNVD
Glioblastoma multiforme	21138945	CNVD
Cancer	20164919	CNVD
Multiple sclerosis	20663923	CNVD
Schizophrenia	20663923	CNVD
brain infarct	20663923	CNVD
Breast cancer	22522925	CNVD
Breast cancer	17142309	CNVD
Schizophrenia	23813976	CNVD
Cancer	20164920	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:930 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:14189200-14190600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
2	chr20:14189200-14191600	Enhancers	Rectal Mucosa Donor 31	rectum
3	chr20:14190000-14190400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
4	chr20:14190400-14191600	Enhancers	Rectal Mucosa Donor 29	rectum
5	chr20:14190400-14194600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
6	chr20:14190600-14191000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
7	chr20:14191000-14191400	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr20:14191400-14191800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr20:14193600-14193800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
10	chr20:14193800-14200400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
11	chr20:14194600-14194800	Enhancers	A549	lung
12	chr20:14194600-14195200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
13	chr20:14194800-14195200	Flanking Active TSS	A549	lung
14	chr20:14195200-14200000	Weak transcription	A549	lung
15	chr20:14200000-14200200	Enhancers	A549	lung
16	chr20:14200200-14200400	Enhancers	HUES6 Cell Line	embryonic stem cell
17	chr20:14200200-14200400	Enhancers	Hela-S3	cervix
18	chr20:14200200-14200600	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
19	chr20:14200200-14201000	Enhancers	Rectal Mucosa Donor 29	rectum
20	chr20:14200200-14201000	Enhancers	Rectal Mucosa Donor 31	rectum
21	chr20:14200200-14201200	Flanking Active TSS	A549	lung
22	chr20:14200200-14201400	Enhancers	Fetal Heart	heart
23	chr20:14200200-14201800	Enhancers	Fetal Intestine Large	intestine
24	chr20:14200200-14202200	Enhancers	HMEC	breast
25	chr20:14200400-14200600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
26	chr20:14200400-14200600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
27	chr20:14200400-14200600	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
28	chr20:14200400-14200600	Enhancers	Skeletal Muscle Male	skeletal muscle
29	chr20:14200400-14200800	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
30	chr20:14200400-14200800	Enhancers	Skeletal Muscle Female	skeletal muscle
31	chr20:14200400-14200800	Enhancers	Small Intestine	intestine
32	chr20:14200400-14201000	Enhancers	iPS-15b Cell Line	embryonic stem cell
33	chr20:14200400-14201000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr20:14200400-14201000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr20:14200400-14201200	Enhancers	Stomach Mucosa	stomach
36	chr20:14200400-14201200	Flanking Active TSS	Hela-S3	cervix
37	chr20:14200400-14201400	Enhancers	HUES48 Cell Line	embryonic stem cell
38	chr20:14200400-14201400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
39	chr20:14200400-14201400	Enhancers	Esophagus	oesophagus
40	chr20:14200400-14201600	Enhancers	NHEK	skin
41	chr20:14200400-14201800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
42	chr20:14200400-14201800	Enhancers	Fetal Intestine Small	intestine
43	chr20:14200400-14202400	Enhancers	ES-I3 Cell Line	embryonic stem cell
44	chr20:14200400-14203200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
45	chr20:14200400-14204000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
46	chr20:14200600-14200800	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr20:14200600-14201400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
48	chr20:14200600-14201600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
49	chr20:14200600-14201600	Enhancers	iPS-18 Cell Line	embryonic stem cell
50	chr20:14200600-14202200	Enhancers	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links